JP2012511026A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012511026A5 JP2012511026A5 JP2011539761A JP2011539761A JP2012511026A5 JP 2012511026 A5 JP2012511026 A5 JP 2012511026A5 JP 2011539761 A JP2011539761 A JP 2011539761A JP 2011539761 A JP2011539761 A JP 2011539761A JP 2012511026 A5 JP2012511026 A5 JP 2012511026A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- lipid
- fragment
- amino acid
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000002632 lipids Chemical class 0.000 claims 29
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 21
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 21
- 125000003275 alpha amino acid group Chemical group 0.000 claims 15
- 238000000034 method Methods 0.000 claims 14
- 239000000427 antigen Substances 0.000 claims 13
- 108091007433 antigens Proteins 0.000 claims 13
- 102000036639 antigens Human genes 0.000 claims 13
- 230000000975 bioactive effect Effects 0.000 claims 12
- 239000012634 fragment Substances 0.000 claims 11
- 239000003446 ligand Substances 0.000 claims 10
- 239000013078 crystal Substances 0.000 claims 9
- 235000001014 amino acid Nutrition 0.000 claims 7
- 229940024606 amino acid Drugs 0.000 claims 5
- 150000001413 amino acids Chemical class 0.000 claims 5
- 230000000694 effects Effects 0.000 claims 3
- 108010047041 Complementarity Determining Regions Proteins 0.000 claims 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical group NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 2
- 239000004473 Threonine Substances 0.000 claims 2
- 125000000539 amino acid group Chemical group 0.000 claims 2
- 235000003704 aspartic acid Nutrition 0.000 claims 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 2
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 claims 2
- 238000000126 in silico method Methods 0.000 claims 2
- 238000000302 molecular modelling Methods 0.000 claims 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 2
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 claims 2
- 238000006467 substitution reaction Methods 0.000 claims 2
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 claims 2
- 238000002965 ELISA Methods 0.000 claims 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 1
- 238000002441 X-ray diffraction Methods 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 claims 1
- 235000013922 glutamic acid Nutrition 0.000 claims 1
- 239000004220 glutamic acid Substances 0.000 claims 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 claims 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 1
- 229960000310 isoleucine Drugs 0.000 claims 1
- 125000000741 isoleucyl group Chemical group [H]N([H])C(C(C([H])([H])[H])C([H])([H])C([H])([H])[H])C(=O)O* 0.000 claims 1
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims 1
- 150000007523 nucleic acids Chemical group 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 238000007670 refining Methods 0.000 claims 1
- 150000003408 sphingolipids Chemical class 0.000 claims 1
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 claims 1
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 claims 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 1
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12031808P | 2008-12-05 | 2008-12-05 | |
| US61/120,318 | 2008-12-05 | ||
| US15589509P | 2009-02-26 | 2009-02-26 | |
| US61/155,895 | 2009-02-26 | ||
| US23125809P | 2009-08-04 | 2009-08-04 | |
| US61/231,258 | 2009-08-04 | ||
| PCT/US2009/066862 WO2010065921A2 (en) | 2008-12-05 | 2009-12-04 | Antibody design using anti-lipid antibody crystal structures |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012511026A JP2012511026A (ja) | 2012-05-17 |
| JP2012511026A5 true JP2012511026A5 (enExample) | 2012-06-28 |
Family
ID=42233904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011539761A Pending JP2012511026A (ja) | 2008-12-05 | 2009-12-04 | 抗脂抗体結晶構造を用いた抗体設計 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20110044990A1 (enExample) |
| EP (1) | EP2374001A4 (enExample) |
| JP (1) | JP2012511026A (enExample) |
| KR (1) | KR20110097923A (enExample) |
| CN (1) | CN102573905A (enExample) |
| AU (1) | AU2009322185A1 (enExample) |
| CA (1) | CA2745436A1 (enExample) |
| IL (1) | IL213358A0 (enExample) |
| WO (1) | WO2010065921A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011153416A2 (en) * | 2010-06-04 | 2011-12-08 | Lpath, Inc. | Novel anti-s1p antibody variants of lt1009 |
| ITRM20100441A1 (it) * | 2010-08-05 | 2012-02-06 | Michele Pitaro | Procedimento per la produzione di anticorpi monoclonali anti-idiotipo ad uso diagnostico e/o terapeutico |
| ES2859574T3 (es) * | 2012-08-07 | 2021-10-04 | Massachusetts Inst Technology | Anticuerpos de antivirus del dengue y usos de los mismos |
| KR20160119806A (ko) | 2014-02-11 | 2016-10-14 | 메사추세츠 인스티튜트 오브 테크놀로지 | 신규한 온전한 범위의 항-뎅기 항체 |
| EP3212173A4 (en) | 2014-10-30 | 2018-06-20 | Textile-Based Delivery, Inc. | Delivery systems |
| WO2017107973A1 (zh) * | 2015-12-24 | 2017-06-29 | 凯惠科技发展(上海)有限公司 | 一种tpbg抗体及其制备方法、其偶联物和应用 |
| WO2018052131A1 (ja) * | 2016-09-16 | 2018-03-22 | 国立大学法人大阪大学 | 免疫実体クラスタリングソフトウェア |
| US11680110B2 (en) | 2017-07-31 | 2023-06-20 | Hoffmann-La Roche Inc. | Three-dimensional structure-based humanization method |
| CN107480360B (zh) * | 2017-08-03 | 2020-04-24 | 中北大学 | 光束细分和相界面漫反射的激光烧熔的数值计算方法 |
| CN109837250B (zh) * | 2019-01-15 | 2021-10-12 | 中国农业科学院兰州兽医研究所 | 羔羊睾丸支持细胞永生化细胞系及其建立方法和应用 |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) * | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5225539A (en) * | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US6548640B1 (en) * | 1986-03-27 | 2003-04-15 | Btg International Limited | Altered antibodies |
| US5567610A (en) * | 1986-09-04 | 1996-10-22 | Bioinvent International Ab | Method of producing human monoclonal antibodies and kit therefor |
| JP3101690B2 (ja) * | 1987-03-18 | 2000-10-23 | エス・ビィ・２・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| GB8823869D0 (en) * | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5175384A (en) * | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
| US20030229208A1 (en) * | 1988-12-28 | 2003-12-11 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5229275A (en) * | 1990-04-26 | 1993-07-20 | Akzo N.V. | In-vitro method for producing antigen-specific human monoclonal antibodies |
| JP4124480B2 (ja) * | 1991-06-14 | 2008-07-23 | ジェネンテック・インコーポレーテッド | 免疫グロブリン変異体 |
| ES2136092T3 (es) * | 1991-09-23 | 1999-11-16 | Medical Res Council | Procedimientos para la produccion de anticuerpos humanizados. |
| US5932448A (en) * | 1991-11-29 | 1999-08-03 | Protein Design Labs., Inc. | Bispecific antibody heterodimers |
| US5777085A (en) * | 1991-12-20 | 1998-07-07 | Protein Design Labs, Inc. | Humanized antibodies reactive with GPIIB/IIIA |
| ATE244763T1 (de) * | 1992-02-11 | 2003-07-15 | Cell Genesys Inc | Erzielen von homozygotem durch zielgerichtete genetische ereignisse |
| US5714350A (en) * | 1992-03-09 | 1998-02-03 | Protein Design Labs, Inc. | Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region |
| US6129914A (en) * | 1992-03-27 | 2000-10-10 | Protein Design Labs, Inc. | Bispecific antibody effective to treat B-cell lymphoma and cell line |
| US5573905A (en) * | 1992-03-30 | 1996-11-12 | The Scripps Research Institute | Encoded combinatorial chemical libraries |
| GB9223377D0 (en) * | 1992-11-04 | 1992-12-23 | Medarex Inc | Humanized antibodies to fc receptors for immunoglobulin on human mononuclear phagocytes |
| US6210671B1 (en) * | 1992-12-01 | 2001-04-03 | Protein Design Labs, Inc. | Humanized antibodies reactive with L-selectin |
| GB9325182D0 (en) * | 1993-12-08 | 1994-02-09 | T Cell Sciences Inc | Humanized antibodies or binding proteins thereof specific for t cell subpopulations exhibiting select beta chain variable regions |
| US5534615A (en) * | 1994-04-25 | 1996-07-09 | Genentech, Inc. | Cardiac hypertrophy factor and uses therefor |
| US5731168A (en) * | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US6096871A (en) * | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| US7060808B1 (en) * | 1995-06-07 | 2006-06-13 | Imclone Systems Incorporated | Humanized anti-EGF receptor monoclonal antibody |
| US5882644A (en) * | 1996-03-22 | 1999-03-16 | Protein Design Labs, Inc. | Monoclonal antibodies specific for the platelet derived growth factor β receptor and methods of use thereof |
| US5834597A (en) * | 1996-05-20 | 1998-11-10 | Protein Design Labs, Inc. | Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same |
| US6013256A (en) * | 1996-09-24 | 2000-01-11 | Protein Design Labs, Inc. | Method of preventing acute rejection following solid organ transplantation |
| PT1034298E (pt) * | 1997-12-05 | 2012-02-03 | Scripps Research Inst | Humanização de anticorpo murino |
| CA2323787A1 (en) * | 1998-03-13 | 1999-09-16 | Wayne Marasco | Humanized antibody and uses thereof |
| JP2002531466A (ja) * | 1998-12-01 | 2002-09-24 | プロテイン デザイン ラブス， インコーポレイテッド | γ−インターフェロンに対するヒト化抗体 |
| US20030096022A1 (en) * | 2000-12-22 | 2003-05-22 | Medlyte, Inc. | Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
| AU2003217912A1 (en) * | 2002-03-01 | 2003-09-16 | Xencor | Antibody optimization |
| US7678386B2 (en) * | 2002-07-15 | 2010-03-16 | Board Of Regents The University Of Texas | Liposomes coated with selected antibodies that bind to aminophospholipids |
| US7794713B2 (en) * | 2004-04-07 | 2010-09-14 | Lpath, Inc. | Compositions and methods for the treatment and prevention of hyperproliferative diseases |
| AU2006294870B2 (en) * | 2005-09-23 | 2011-08-04 | WRAIR, a U.S Army Research institution under the United States Government, as represented by the Secretary of the Army | Antibodies with simultaneous subsite specificities to protein and lipid epitopes |
| US20080213274A1 (en) * | 2005-10-28 | 2008-09-04 | Sabbadini Roger A | Compositions and methods for the treatment and prevention of fibrotic, inflammatory, and neovascularization conditions of the eye |
| US8796429B2 (en) * | 2006-05-31 | 2014-08-05 | Lpath, Inc. | Bioactive lipid derivatives, and methods of making and using same |
| US9274129B2 (en) * | 2006-05-31 | 2016-03-01 | Lpath, Inc. | Methods and reagents for detecting bioactive lipids |
| US20080138334A1 (en) * | 2006-05-31 | 2008-06-12 | Sabbadini Roger A | Immune-Derived Moieties Reactive Against Bioactive Lipids, and Methods of Making and Using Same |
| CN101687031B (zh) * | 2006-10-27 | 2014-05-14 | 勒帕斯公司 | 用于治疗眼疾和眼病的组合物及方法 |
| ZA200902860B (en) * | 2006-10-27 | 2010-07-28 | Lpath Inc | Compositions and methods for binding sphingosine-1-phosphate |
-
2009
- 2009-12-04 KR KR1020117015390A patent/KR20110097923A/ko not_active Withdrawn
- 2009-12-04 WO PCT/US2009/066862 patent/WO2010065921A2/en not_active Ceased
- 2009-12-04 AU AU2009322185A patent/AU2009322185A1/en not_active Abandoned
- 2009-12-04 CN CN2009801562855A patent/CN102573905A/zh active Pending
- 2009-12-04 JP JP2011539761A patent/JP2012511026A/ja active Pending
- 2009-12-04 US US12/631,784 patent/US20110044990A1/en not_active Abandoned
- 2009-12-04 CA CA2745436A patent/CA2745436A1/en not_active Abandoned
- 2009-12-04 EP EP09831241A patent/EP2374001A4/en not_active Withdrawn
-
2011
- 2011-06-05 IL IL213358A patent/IL213358A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012511026A5 (enExample) | ||
| JP7668617B2 (ja) | ｐＨ依存的抗体の調製方法 | |
| JP2018535670A5 (enExample) | ||
| RU2008126948A (ru) | Связывающие полипептиды и их применения | |
| JP2017503787A (ja) | モノクローナル抗ｔｋ１抗体 | |
| RU2015129813A (ru) | Антитела, которые связываются с лигандом запрограммированной клеточной смерти 1 (pd-l1) | |
| NZ602621A (en) | Antibodies against csf-1r | |
| JP2007530068A5 (enExample) | ||
| JP2018521638A5 (enExample) | ||
| JP2009517057A5 (enExample) | ||
| JP2020537520A5 (enExample) | ||
| JP2007501011A5 (enExample) | ||
| JP2022133350A (ja) | 分析目的のための多価単一または二重特異性組換え抗体 | |
| Nahshol et al. | Parallel kinetic analysis and affinity determination of hundreds of monoclonal antibodies using the ProteOn XPR36 | |
| JP2025111457A5 (enExample) | ||
| CN113677701B (zh) | 产生亲合结合多特异性抗体的方法 | |
| CN114555642A (zh) | 提升抗体对于抗原的亲和性的方法及其利用 | |
| Murphy et al. | Enhancing recombinant antibody performance by optimally engineering its format | |
| US20240400672A1 (en) | Novel monoclonal antibodies directed against l-thyroxine and diagnostic uses thereof | |
| US20110275857A1 (en) | Antibody-Guided Fragment Growth | |
| JP2018535403A (ja) | 黒色腫の診断マーカーとしてのｇｄｆ−１５ | |
| JP7691234B2 (ja) | 抗体の抗原に対する親和性を向上させる方法及びその利用 | |
| US10414818B2 (en) | Thermus thermophilus SlyD FKBP domain specific antibodies | |
| CN117126283B (zh) | 抗pic的抗体、试剂盒及检测pic的方法 | |
| JPWO2019173503A5 (enExample) |